| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/2011 | CN102099049A Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 06/15/2011 | CN102099048A Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 06/15/2011 | CN102099013A Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 06/15/2011 | CN102094043A Construction and application of recombinant pig chemotactic factor CXCL12 mammalian cell expression plasmid |
| 06/15/2011 | CN102093993A Kringle 5 mutant protein, and preparation method and application thereof |
| 06/15/2011 | CN102093964A Tomato-derived lactic acid bacteria with functions of resisting oxidation and lowering blood fat |
| 06/15/2011 | CN102093480A Recombinant human serum albumin-interferon alpha 1b fusion protein and preparation method thereof |
| 06/15/2011 | CN102093475A Analogue of glucagon like peptide-1 |
| 06/15/2011 | CN102093471A Angiotensin I transferase inhibitor and preparation method and application thereof |
| 06/15/2011 | CN102093469A Milk-derived antioxidant active peptide and composition thereof |
| 06/15/2011 | CN102093440A Coproduction process of pig brain protein hydrolysate and monosialoganglioside |
| 06/15/2011 | CN102091326A Transdermal medicament delivery preparation for treating hemorrhoid diseases caused by expansion or varix of anal subcutaneous veniplex and preparation method thereof |
| 06/15/2011 | CN102091325A Enzymic digestion hemorrhoids ointment and method for preparing same from potato |
| 06/15/2011 | CN102091324A Calcium for nourishing bones |
| 06/15/2011 | CN102091323A Compound preparation of collagen powder and preparation method thereof |
| 06/15/2011 | CN102091322A Compound preparation of collagen tablet and preparation method thereof |
| 06/15/2011 | CN102091321A Medicament oral liquid for treating enteritis and diarrhea and preparation method thereof |
| 06/15/2011 | CN102091320A Toad peptide antibiotics for preparing medicine for treating liver cancer |
| 06/15/2011 | CN102091319A Toad peptide antibiotic for preparing medicaments for treating herpes zoster |
| 06/15/2011 | CN102091318A Toad peptide antibiotics separated from toad maggots and preparation method of antibacterial drugs thereof |
| 06/15/2011 | CN102091278A Selenium- and germanium-enriched lucid ganoderma mycelium snake nano metallothionein capsule |
| 06/15/2011 | CN102091090A Methods and compositions for the treatment of inflammation |
| 06/15/2011 | CN102091056A Cell microcapsule for treating parkinsonism and composite cytoskeleton |
| 06/15/2011 | CN102091043A Growth factor slow release microballoon and preparation method thereof |
| 06/15/2011 | CN102090558A Composition containing probiotics, DHA (docosahexaenoic acid) and lactoferrin and applications thereof |
| 06/15/2011 | CN101549152B Alliin/alliinase dualistic drug-releasing multilayer tablet |
| 06/15/2011 | CN101502647B Medicament composition for preventing or/and treating decayed tooth and preparation method thereof |
| 06/15/2011 | CN101444483B Sustained-release preparation containing chemotherapy synergist for treating solid tumors |
| 06/15/2011 | CN101434964B Cholera toxin B subunit and lumbrokinase fusion gene, as well as recombinant vector and host cell including the same |
| 06/15/2011 | CN101392020B Musca domestic pupae natural antimicrobial peptide products and preparation method and use thereof |
| 06/15/2011 | CN101294188B Lactoferrin antimicrobial peptide, preparing method and uses thereof |
| 06/15/2011 | CN101229320B Glutathione ammoniacum compounds and processing method thereof |
| 06/15/2011 | CN101195657B Type I cell factor receptor sample molecule, encoding gene and application thereof |
| 06/15/2011 | CN101094847B Aryloxy-substituted benzimidazole derivatives |
| 06/15/2011 | CN101027076B Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 06/15/2011 | CN101010338B Muteins of fibroblast growth factor 21 |
| 06/14/2011 | US7960570 Small molecule inhibitors of rotamase enzyme activity |
| 06/14/2011 | US7960529 Bone delivery conjugates and method of using same to target proteins to bone |
| 06/14/2011 | US7960527 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 06/14/2011 | US7960519 Protein recovery using fatty alcohol, salt and buffer for lysis; nucleic acid precipitate; use in gel electrophoresis, immunoprecipitation, activity assay |
| 06/14/2011 | US7960514 IL-7 fusion proteins |
| 06/14/2011 | US7960508 A peptide fragment containing selenocysteine has a lowered toxicity than selenocystine, exhibits a cytotoxicity-inhibitory activity; screening a drug having cytotoxicity-inhibitory activity by utilizing a cellular sudden death phenomenon in a cell culture system; glutathione peroxidase activity |
| 06/14/2011 | US7960505 Lantibiotics and uses thereof |
| 06/14/2011 | US7960437 Improving aesthetic appearance of skin by reducing wrinkles and fine lines, improving smoothness, texture, firmness, moisture, elasticity and resilience; topical application of a mixture of a phtyol and a cyclic-AMP derivative |
| 06/14/2011 | US7960420 Diazonamide analogs with improved solubility |
| 06/14/2011 | US7960398 Potent inhibitors of TNF activity |
| 06/14/2011 | US7960358 Antisense modulation of stearoyl-CoA desaturase expression |
| 06/14/2011 | US7960350 Comprises N-alpha-acetyl-L-histidine; kits; droppers |
| 06/14/2011 | US7960349 N-terminally modified GLP-1 receptor modulators |
| 06/14/2011 | US7960348 Metastin derivatives and use thereof |
| 06/14/2011 | US7960347 Matrix protein compositions for induction of apoptosis |
| 06/14/2011 | US7960346 glycoprotein-120 or Nef proteins (isolated from human immunodeficiency virus) for killing epithelial cell carcinomas |
| 06/14/2011 | US7960344 Methods of enhancing functioning of the large intestine |
| 06/14/2011 | US7960343 Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion |
| 06/14/2011 | US7960342 Side effect reduction; block receptor function so they can be used in therapy; labeled with radioactive iodine; drug screening |
| 06/14/2011 | US7960341 Methods and compositions for treating polycystic ovary syndrome |
| 06/14/2011 | US7960340 Cystine knot molecules |
| 06/14/2011 | US7960339 Antimicrobial peptides |
| 06/14/2011 | US7960337 Parenteral combination therapy for infective conditions with drug resistant bacterium |
| 06/14/2011 | US7960336 Composition for long-acting peptide analogs |
| 06/14/2011 | US7960335 Octreotide implant having a release agent and uses thereof |
| 06/14/2011 | US7960334 Use of ADNF III polypeptides for treating mental diseases and disorders, including schizophrenia |
| 06/14/2011 | US7960163 Matriptase, a serine protease and its applications |
| 06/14/2011 | US7960118 EGFR mutations |
| 06/14/2011 | US7960102 Regulated aptamer therapeutics |
| 06/14/2011 | US7959956 Method for treating diabetic complications |
| 06/14/2011 | US7959954 Pharmaceutical composition for treatment of diabetes and dyslipidemia |
| 06/14/2011 | US7959933 Activatable recombinant neurotoxins |
| 06/14/2011 | US7959926 Using hydrophobic interaction chromatography (HIC) matrix to recover somatotropins |
| 06/14/2011 | US7959919 Administering antibody, peptides, oligonucleotides, peptitomimetics, or small organic molecules having a binding region specific to factor B; antiinflammatory agent treating rheumatoid arthritis, anaphylactic shock, myasthenia gravis, asthma, Alzheimer's disease, cardiopulmonary bypass inflammation |
| 06/14/2011 | US7959914 Methods of reducing extravasation of inflammatory cells |
| 06/14/2011 | US7959913 Applying a mixture of a retinoid, antimicotic compound that enhances conversion of retinoid to retinoic acid and prevents the retinoic acid degradation (bifonazole, climbazole), fatty alcohol and/or fatty acid, and cosmetic vehicle to treat the skin for wrinkles, psoriasis, age spots or discoloration. |
| 06/14/2011 | US7959910 C-terminally truncated interferon alpha variants |
| 06/14/2011 | US7959909 Cysteine variants of interferon gamma |
| 06/14/2011 | US7959908 Methods of treating viral infections using IL-21 |
| 06/14/2011 | US7959907 Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide |
| 06/14/2011 | US7959901 EGFR inhibitors promote axon regeneration |
| 06/14/2011 | US7959659 Bioabsorbable stents; vascular disorders, occlusion treatment such as restenosis or vulnerable plaque; atherosclerosis, diabetes; anticoagulants |
| 06/14/2011 | CA2600177C Human skin equivalents expressing exogenous polypeptides |
| 06/14/2011 | CA2566301C Novel use of peptide compounds for treating essential tremor and other tremor syndromes |
| 06/14/2011 | CA2494241C Botulinum toxin pharmaceutical compositions |
| 06/14/2011 | CA2492378C Modified amino acid for the inhibition of platelet aggregation |
| 06/14/2011 | CA2476177C Purification of red blood cells by separation and diafiltration |
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2458267C Bifunctional chelating agent for actinium |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2413546C Modification of hepatitis b core antigen |
| 06/14/2011 | CA2405084C Neutralizing immunogenic hev polypeptides |
| 06/14/2011 | CA2369591C Disodium salts, monohydrate, and ethanol solvates |
| 06/14/2011 | CA2349490C Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
| 06/14/2011 | CA2338419C Pulmonary delivery of active agents |
| 06/14/2011 | CA2311646C Tsa305 gene |
| 06/14/2011 | CA2301327C Use of herpes vectors for tumor therapy |
| 06/14/2011 | CA2297786C New immunoprotective influenza antigen and its use in vaccination |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/14/2011 | CA2200540C Use of l-carnitine or derivatives thereof and antioxidants for the prevention and treatment of diseases elicited by oxidative stress to the nervous and cardiovascular system |
| 06/14/2011 | CA2182621C Galanin receptor, nucleic acids, transformed cells and uses thereof |
| 06/09/2011 | WO2011069164A2 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
| 06/09/2011 | WO2011069090A1 Inhibition of the activation of coagulation factor xii by ligands of phosphatidylserine |
| 06/09/2011 | WO2011069051A1 Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions |